GSK · story · 9 November – 12 November

GSK has two investor conferences coming up

GSK · 7 headlines from 2 outlets, from 9 November 2026 to 12 November 2026.

GSK dashboard

+2.7slightly positive

+2.7

Headlines7

Outlets2

Days49 November – 12 November

GSK presents at the Guggenheim healthcare conference, emphasising long-acting biologics and pipeline focus.

Tone by day

Average of each day's headlines, −10 to +10.

Source: MarketFrame news analysis

Tone by day. Average of each day's headlines, −10 to +10. Source: MarketFrame news analysis
day	Average tone
9 Nov	0.8
10 Nov	5.6
11 Nov	2.0
12 Nov	−0.4

The story's tone is the average of its headlines' own scores. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.

Every outlet, by impact on the tone

Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone.

Source: MarketFrame news analysis

Every outlet, by impact on the tone. Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone. Source: MarketFrame news analysis
outlet	Average tone
AD HOC NEWS	2.3
Investing.com	5.0

Outlet	Headlines	Average tone
AD HOC NEWS	6	+2.3
Investing.com	1	+5.0

One or two headlines is not a lean: read these as how this story was told, not as a verdict on the outlet.

Tone	What the article reported, and why it scored that way	Source
−1.7	Small share price dip with focus on upcoming pipeline events.	AD HOC NEWS (opens the article) ↗
+0.8	Pipeline emphasis continues following investor conference appearance.	AD HOC NEWS (opens the article) ↗

GSK on 12 November

Tone	What the article reported, and why it scored that way	Source
+2.0	Investor attention on pipeline ahead of a conference.	AD HOC NEWS (opens the article) ↗

GSK on 11 November

Tone	What the article reported, and why it scored that way	Source
+6.7	Growth led by Specialty Medicines ahead of investor events.	AD HOC NEWS (opens the article) ↗
+5.0	Conference presentation highlighting long-acting biologics strategy.	Investing.com (opens the article) ↗
+5.0	Pipeline emphasis presented at investor healthcare conference.	AD HOC NEWS (opens the article) ↗

GSK on 10 November

Tone	What the article reported, and why it scored that way	Source
+0.8	Upcoming investor conference appearances, mostly routine scheduling.	AD HOC NEWS (opens the article) ↗

GSK on 9 November

A short, free morning email on how the news treated GSK: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.

GSK has two investor conferences coming up

The story

Tone by day

How each outlet covered it · 2 outlets

Every outlet, by impact on the tone

Day by day · 4 days, strongest headlines first

Follow by email